Compound Report Overview
Compound Name:
2-3(S)-2(R)-(N-HYDROXYCARBAMOYLMETHYL)DECANAMIDO-2-OXOPERHYDROAZEPIN-1-YLACETIC ACID METHYL ESTER
Compound Identifier:
704115
Development Status:
Clinical Phase I
SMILES:
CCCCCCCCC(CC(O)NO)C(O)NC1CCCCN(CC(O)OC)C1O